Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells

Lei Wu, Xudong Liu, Juan Lei, Nan Zhang, Huakan Zhao, Jiangang Zhang, Huan Deng, Yongsheng Li · 2023

Read Fibrinogen-like protein 2 promotes tumor immune suppression by regulating cholesterol metabolism in myeloid-derived suppressor cells by Lei Wu, Xudong Liu, Juan Lei, Nan Zhang, Huakan Zhao, Jiangang Zhang, Huan Deng, Yongsheng Li (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10711877.txt.

Description

Lei Wu and co-authors uncover a protein that helps tumors hide from the immune system in a 2023 study. The protein, fibrinogen-like protein 2, acts on myeloid-derived suppressor cells, immune cells that tumors recruit to blunt attack. Taming those cells is a known route to stronger immunotherapy.

In mouse tumor models, removing the protein boosted killer T cell responses and cut the build-up of one suppressor cell type. The protein works by steering cholesterol handling inside the suppressor cells. That shift raises reactive oxygen output and fires a stress signal, which locks in their suppressive state. Blocking the protein or its cholesterol pathway freed the cells to mature instead. Pairing such a block with a standard checkpoint drug, the authors suggest, could sharpen cancer treatment.

Catalog record

CREATORLei Wu, Xudong Liu, Juan Lei, Nan Zhang, Huakan Zhao, Jiangang Zhang, Huan Deng, Yongsheng Li
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10711877

Browse the full library · About the Tower of Babel